IIARD International Institute of Academic Research and Development

INTERNATIONAL JOURNAL OF HEALTH AND PHARMACEUTICAL RESEARCH (IJHPR )

E-ISSN 2545-5737
P-ISSN 2695-2165
VOL. 9 NO. 4 2024
DOI: 10.56201/ijhpr.v9.no4.2024.pg104.128

---

The Role of High Sensitivity C- Reactive Protein Level in Predicting Stroke and Other Cardiovascular Events: A Meta-Analysis Review

Abigail Biya

---

Abstract

Background: Stroke stands as a prominent cause of morbidity and mortality on a global scale. Inflammation assumes a pivotal role in the advancement of stroke, with high-sensitivity C-reactive protein (hs-CRP) showing promise as a potential biomarker for assessing the risk of stroke. Aim: This meta-analysis seeks to evaluate the predictive capacity of hs-CRP in relation to stroke by comparing hs-CRP levels in stroke patients with those in non-stroke subjects (apparently healthy individuals) and patients with other cardiovascular events versus controls. Method: A comprehensive search across PubMed, Web of Science, EMBASE, and the Cochrane Library identified studies published from January 2010 to June 2024. Inclusion criteria focused on case- control or cohort studies reporting quantitative hs-CRP levels in stroke and cardiovascular events alongside control groups. Studies were rigorously screened and selected based on predefined criteria (randomised control trials). Data from 13 selected studies were extracted and analysed using RevMan 5.4.1 review manager. Findings: The meta-analysis included data from 13 studies with a total sample size of 1,486 subjects. The primary comparator analysis showed significantly higher hs-CRP levels in stroke patients than in non-stroke controls (Standardised Mean difference: 0.85 mg/L, 95% CI: 0.4,1.29; p= 0.0002). The secondary comparator analysis demonstrated elevated hs-CRP levels in patients who experienced other cardiovascular events compared to the control group (Standardised Mean Difference: 2.20 mg/L; 96% CI: 1.22, 3.18; p < 0.00001). These findings indicate that increased hs-CRP levels are associated with a heightened risk of stroke and other cardiovascular events. This underscores the potential of hs-CRP as a valuable biomarker in stroke and cardiovascular disease risk assessment. Conclusion: hs-CRP measurement can enhance stroke prediction models, facilitating early intervention and impr

keywords:

high-sensitivity C-reactive protein, hs-CRP, stroke, cardiovascular event, biomarker

---

References:

AL-Sa’adi, W., Warka’a, T., Abdulmunem, R. and Raed, L. (2015) 'Hs-CRP and Haptoglobin
Levels in Iraqi Patients with Coronary Artery Disease’, Journal of the Faculty of Medicine
Baghdad, 57(1), pp. 84-86. Available at: https://doi.org/10.32007/jfacmedbagdad.571318
Al-Hindi, H., Mousa, M., Al-Kashwan, T., Sudan, A. and Abdul-Razzaq, S. (2019) ‘On admission
levels of high sensitive C-Reactive protein as A biomarker in acute myocardial infarction:
A case-control study’, Indian Journal of Public Health, 10(4), p.1481.Available at:
https://doi.org/10.5958/0976-5506.2019.00924.0
Andersson, J., Johansson, L., Ladenvall, P., Wiklund, P., Stegmayr, B., Jern, C. and Boman, K.
(2009) ‘C-reactive protein is a determinant of first-ever stroke: Prospective nested case-
referent study’, Cerebrovascular diseases (Basel, Switzerland), 27(6), pp. 544–551.
Available at: https://doi.org/10.1159/000214217
Ansar, W. and Ghosh, S. (2013) ‘C-reactive protein and the biology of disease’, Immunologic
research, 56(1), pp. 131–142. Available at: https://doi.org/10.1007/s12026-013-8384-0
Banait, T., Wanjari, A., Danade, V., Banait, S. and Jain, J. (2022) ‘Role of high-sensitivity C-
reactive protein (Hs-CRP) in non-communicable diseases: A review’, Cureus, 14(10),
Available at: https://doi.org/10.7759/cureus.30225
Béjot, Y., Bailly, H., Durier, J. and Giroud, M. (2016) ‘Epidemiology of stroke in Europe and
trends for the 21st century’, La Presse Médicale, 45(12), pp. e391–e398. Available at:
https://doi.org/10.1016/j.lpm.2016.10.003
Bienek, R., Marek, B., Kajdaniuk, D., Borgiel-Marek, H., Piecha, T., Nowak, M., Siemi?ska, L.,
G?ogowska-Szel?g, J., Foltyn, W. and Kos-Kud?a, B. (2012) ‘Adiponectin, leptin, resistin
and insulin blood concentrations in patients with ischaemic cerebral stroke’,
Endokrynologia
Polska,
63(5),
pp.338-345.
Available
at:
https://journals.viamedica.pl/endokrynologia_polska/article/view/25144(Accessed
on
04/08/2024)
Boehme, A., Esenwa, C. and Elkind, M. (2017) ‘Stroke risk factors, genetics, and prevention’,
Circulation
research,
120(3),
pp.472-495.
Available
at:
https://doi.org/10.1161/CIRCRESAHA.116.308398
Donkor, E. (2018) ‘Stroke in the21stCentury: A snapshot of the burden, epidemiology, and quality
of life’, Stroke research and treatment, 2018(1), pp. 3238165. Available at:
https://doi.org/10.1155/2018/3238165
Flora, G. D., & Nayak, M. K. (2019). A brief review of cardiovascular diseases, associated risk
factors and current treatment regimes. Current pharmaceutical design, 25(38), 4063-4084.
Frak, W., Wojtasinska, A., Lisinska, W., Mlynarska, E., Franczyk, B. and Rysz, J. (2022)
‘Pathophysiology of Cardiovascular diseases: New insights into Molecular mechanisms of
atherosclerosis, arterial hypertension, and coronary artery disease’, Biomedicines, 10(8),
pp. 1938. Available at: https://doi.org/10.3390/biomedicines10081938
Gagnier, J., Moher, D., Boon, H., Beyene, J. and Bombardier, C. (2012) ‘Investigating clinical
heterogeneity in systematic reviews: a methodologic review of guidance in the
literature’, BMC medical research methodology, 12(1), pp. 111. Available at:
https://doi.org/10.1186/1471-2288-12-111
Gan, Y., Jiang, H., Room, R., Zhan, Y., Li, L., Lu, K. and Wang, C. (2021) ‘Prevalence and risk
factors associated with stroke in China: a nationwide survey of 726,451 adults’, European
journal
of
preventive
cardiology,
28(12),
pp.
e6–e10.Available
at:
https://doi.org/10.1177/2047487320902324
Golbidi, S., Frisbee, J. and Laher, I. (2015) ‘Chronic stress impacts the cardiovascular system:
animal models and clinical outcomes’, American Journal of Physiology-Heart and
Circulatory Physiology, 308(12), Available at: https://doi.org/H-00859-2014
Golledge, J., Velu, R., Quigley, F., Jenkins, J. and Singh, T. (2023) ‘The predictive value of four
serum biomarkers for major adverse events in patients with small abdominal aortic
aneurysm’, Journal of vascular surgery, 77(4), pp. 1037–1044. Available at:
https://doi.org/10.1016/j.jvs.2022.12.001
Huang, Y., Jing, J., Zhao, X., Wang, C., Wang, Y., Liu, G., Wang, C., Liu, L., Yang, X., Jiao, Y.
and Jiao, Y. (2012) ‘High?sensitivity C?reactive protein is a strong risk factor for death
after acute ischemic stroke among Chinese’, CNS neuroscience & therapeutics, 18(3),
pp.261-266. Available at: https://doi.org/10.1111/j.1755-5949.2012.00296.x
Kara, H., Akinci, M., Degirmenci, S., Bayir, A., Ak, A., Nayman, A., Unlu, A., Akyurek, F. and
Sivri, M. (2014) ‘High-sensitivity C-reactive protein, lipoprotein-related phospholipase
A2, and acute ischemic stroke’, Neuropsychiatric disease and treatment, 10 (2014),
pp.1451-1457. Available at: https://doi.org/10.2147/ndt.s67665.
Koosha, P., Roohafza, H., Sarrafzadegan, N., Vakhshoori, M., Talaei, M., Sheikhbahaei, E. and
Sadeghi, M. (2020) ‘High sensitivity C-reactive protein predictive value for cardiovascular
disease: A nested case control from Isfahan cohort study (ICS)’, Global heart, 15(1), pp.
Available at: https://doi.org/10.5334/gh.367
Kuriakose, D. and Xiao, Z. (2020) ‘Pathophysiology and treatment of stroke: Present status and
future perspectives’, International journal of molecular sciences, 21(20), pp. 7609.
Available at: https://doi.org/10.3390/ijms21207609
Kusvuran Ozkan, A., Umit Yemisci, O., Nur Saracgil Cosar, S., Oztop, P. and Turhan, N. (2013)
‘Can high-sensitivity C-reactive protein and ferritin predict functional outcome in acute
ischemic stroke? A prospective study.’, Topics in Stroke Rehabilitation, 20(6), pp. 528–
Available at: https://doi.org/10.1310/tsr2006-528
Lee, A., Lucero, B., Palmer, L., Jones, J. and Young, J. (2013) ‘Inflammatory biomarkers for
predicting cardiovascular disease’, Clinical biochemistry, 46(15), pp. 1353–1371.
Available at: https://doi.org/10.1016/j.clinbiochem.2013.05.070
Li, W., Xiong, L., Fan, L., Wang, Y., Peng, X., Rong, R., Qiu, Y., Shen, J., Lin, J., Yu, X. and
Mao, H. (2017)’, Association of baseline, longitudinal serum high-sensitive C-reactive
protein and its change with mortality in peritoneal dialysis patients’, BMC nephrology, 18,
pp.1-10. Available at: https://doi.org/10.1186/s12882-017-0624-4.
Lin, F., Chen, Y., Wan, M., Chen, W. and Jia, W. (2019) ‘High-sensitivity C-reactive protein as
an indicator of ischemic stroke in patients with isolated acute vestibular syndrome:
Retrospective observational study’, Medicine, 98(48), pp. e18097. Available at:
https://doi.org/10.1097/md.0000000000018097
Liu, G., Dong, M., Ma, S., Fu, L., Xiao, Y., Zhong, L. and Geng, J. (2019) ‘Serum leptin is
associated with first-ever ischemic stroke, lesion size and stroke severity in a Chinese
cohort’, Neurological
research, 41(2),
pp.
125–131.
Available
at:
https://doi.org/10.1080/01616412.2018.1544399
Liu, Y., Wang, J., Zhang, L., Wang, C., Wu, J., Zhou, Y., Gao, X., Wang, A., Wu, S. and Zhao,
X., 2014 ‘Relationship between C-reactive protein and stroke: a large prospective
community
based
study’,
PloS
one,
9(9),
pp.e107017.Available
at:
https://doi.org/10.1371/journal.pone.0107017
Luan, Y. and Yao, Y. (2018) ‘The clinical significance and potential role of C-reactive protein in
chronic inflammatory and neurodegenerative diseases’, Frontiers in immunology, 9, pp.
1302 doi: https://doi.org/10.3389/fimmu.2018.01302
Maki-Alhindi, H., Mousa, M., Al-kashwan, T., Sudan, A. and Abdul-Razzaq, S. (2019) ‘On
admission levels of high sensitive C-reactive protein as A biomarker in acute myocardial
infarction: A case-control study’, Indian journal of public health research and
development, 10(4),
pp.
Available
at:
https://doi.org/10.5958/0976-
5506.2019.00924.0.
Menon, B. and Krishnan, R. (2018) ‘Role of Leptin in acute ischemic stroke’, Journal of
neurosciences
in
rural
practice, 0

DOWNLOAD PDF

---

Back